HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides

Mathieu, MG, Knights, AJ, Pawelec, G, Riley, CL, Wernet, D, Lemonnier, FA, Straten, PT, Mueller, L, Rees, RC and Mcardle, SE, 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004

Full text not available from this repository.
Item Type: Journal article
Publication Title: Cancer Immunology Immunotherapy
Creators: Mathieu, M.G., Knights, A.J., Pawelec, G., Riley, C.L., Wernet, D., Lemonnier, F.A., Straten, P.T., Mueller, L., Rees, R.C. and Mcardle, S.E.
Date: 2007
Volume: 56
Number: 12
ISSN: 0340-7004
Divisions: Schools > School of Science and Technology
Depositing User: EPrints Services
Date Added: 09 Oct 2015 10:27
Last Modified: 19 Oct 2015 14:32
URI: http://irep.ntu.ac.uk/id/eprint/13151

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year